Literature DB >> 31976902

FLR: A Revolutionary Alignment-Free Similarity Analysis Methodology for DNA-Sequences.

Belal Medhat, Ahmed Shawish.   

Abstract

This paper introduces a novel alignment-free sequence analysis methodology. Its main idea is based on introducing a new representation of the DNA-Sequence. This representation breaks the dependency between the DNA bases that exist in the traditional string presentation. We called it the Four-Lists-Representation (FLR). Based on the FLR, a series of revolutionary algorithms for searching, map-discovery, similarity-score analysis, and similarity-visualization have been developed. They are combined in what we call the FLR Methodology. The paper also studies most of the available similarity analysis techniques in a comprehensive state-of-art review. The conducted extensive simulation and theoretical studies confirm the outperformance of the whole set of FLR-based algorithms in terms of speed and memory consumption in comparison to a long list of available similarity analysis algorithms. The ability to provide a similarity-map, similarity-score, and similarity-graph as a set of evidence-based rationales makes the quality of results provided by the proposed methodology presents a new edge in this field and promises a new area of genome-based research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 31976902     DOI: 10.1109/TCBB.2020.2967385

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  2 in total

1.  Decision Support for Oropharyngeal Cancer Patients Based on Data-Driven Similarity Metrics for Medical Case Comparison.

Authors:  Julia Buyer; Alexander Oeser; Nora Grieb; Andreas Dietz; Thomas Neumuth; Matthaeus Stoehr
Journal:  Diagnostics (Basel)       Date:  2022-04-15

2.  Role of Bioinformatics Analysis in Early Differential Diagnosis of Ovarian Cancer.

Authors:  Lihua Zhang; Yuanyuan Zhao; Li Li; Huadong Xin
Journal:  Contrast Media Mol Imaging       Date:  2022-09-16       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.